Clinical Significance of KRAS Mutations in Circulating Tumor DNA for Appropriate Surgical Indication and Timing in Patients with Borderline Resectable or Unresectable Pancreatic Cancer
Clinical Significance of KRAS Mutations in Circulating Tumor DNA for Appropriate Surgical Indication and Timing in Patients with Borderline Resectable or Unresectable Pancreatic Cancer
复制标题
循环肿瘤 DNA 中 KRAS 突变对于临界可切除或不可切除胰腺癌患者适当手术指征和时机的临床意义
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Yoshida Ryuichi
中科院分区：
文献类型：
--
作者：
Bu L;Yonemura A;Yasuda-Yoshihara N;Uchihara T;Ismagulov G;Takasugi S;Yasuda T;Okamoto Y;Kitamura F;Akiyama T;Arima K;Itoyama R;Zhang J;Fu L;Hu X;Wei;F;Arima Y;Moroishi T;Nishiyama K;Sheng G;Mukunoki T;Otani J;Baba H;Ishimoto T;Yoshida Ryuichi
